NASDAQ:ALT
Altimmune, Inc. Stock News
$7.19
+0.120 (+1.70%)
At Close: May 02, 2024
LegalZoom.com, Toast And Some Other Big Stocks Moving Higher On Friday
03:59pm, Friday, 12'th Aug 2022 Benzinga
Altimmune, Inc. (NASDAQ: ALT) jumped 28% to $17.64. B. Riley Securities maintained Altimmune with a Buy and raised the price target from $21 to $26.
Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) ju
ALTIMMUNE INC (ALT) Q2 2022 Earnings Call Transcript
11:30pm, Thursday, 11'th Aug 2022 The Motley Fool
ALT earnings call for the period ending June 30, 2022.
Altimmune, Inc. (ALT) CEO Vipin Garg on Q2 2022 Results - Earnings Call Transcript
01:44pm, Thursday, 11'th Aug 2022
Altimmune, Inc. (NASDAQ:ALT ) Q2 2022 Results Conference Call August 11, 2022 8:30 AM ET Company Participants Richard Eisenstadt - Chief Financial Officer Vipin Garg - President and Chief Executive Of
Altimmune, Inc. (ALT) Reports Q2 Loss, Misses Revenue Estimates
12:35pm, Thursday, 11'th Aug 2022 Zacks Investment Research
Altimmune, Inc. (ALT) delivered earnings and revenue surprises of 6.67% and 99.54%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Altimmune, Inc. (ALT) Reports Q2 Loss, Misses Revenue Estimates
09:47am, Thursday, 11'th Aug 2022
Altimmune, Inc. (ALT) delivered earnings and revenue surprises of 6.67% and 99.54%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Here's Why Altimmune, Inc. (ALT) is a Great Momentum Stock to Buy
04:00pm, Monday, 18'th Jul 2022 Zacks Investment Research
Does Altimmune, Inc. (ALT) have what it takes to be a top stock pick for momentum investors? Let's find out.
Is Altimmune (ALT) Stock Outpacing Its Medical Peers This Year?
01:40pm, Monday, 18'th Jul 2022 Zacks Investment Research
Here is how Altimmune, Inc. (ALT) and argenex (ARGX) have performed compared to their sector so far this year.
Is Altimmune (ALT) Stock Outpacing Its Medical Peers This Year?
11:37am, Monday, 18'th Jul 2022
Here is how Altimmune, Inc. (ALT) and argenex (ARGX) have performed compared to their sector so far this year.
Molina Healthcare (MOH) to Buy My Choice Wisconsin for $150M
04:54pm, Thursday, 14'th Jul 2022 Zacks Investment Research
Molina Healthcare (MOH) expects the buyout to complement its existing Medicaid business in Wisconsin.
Encompass Health (EHC) to Build New Rehab Unit in Missouri
08:54pm, Wednesday, 13'th Jul 2022 Zacks Investment Research
Encompass Health (EHC) and BJC HealthCare's new rehabilitation hospital is expected to come online in 2024.
Teladoc (TDOC) Widens Primary360 Offerings With New Services
06:57pm, Thursday, 07'th Jul 2022 Zacks Investment Research
Teladoc (TDOC) will provide in-home and on-demand phlebotomy services for its Primary360 members with Scarlet Health's support.
Why You Should Hold Elevance Health (ELV) in Your Portfolio
06:38pm, Thursday, 07'th Jul 2022 Zacks Investment Research
Elevance Health (ELV) continues witnessing a rise in the usage of its virtual care services, which is a vital driver.
Why Pediatrix Medical (MD) is a Solid Bet for Your Portfolio
05:55pm, Tuesday, 05'th Jul 2022 Zacks Investment Research
Pediatrix Medical (MD) is expected to boost its services across maternal-fetal medicine, neonatology and obstetrics, plus 18 pediatric subspecialty offerings.
Here's Why Select Medical (SEM) Stock is a Strong Buy Now
04:42pm, Monday, 04'th Jul 2022 Zacks Investment Research
Strategic alliances are bolstering Select Medical's (SEM) growth potential while mitigating the risk factor.
Universal Health (UHS) Cuts Guidance, Falls 6.1%: What's Ahead?
08:41pm, Friday, 01'st Jul 2022 Zacks Investment Research
Universal Health's (UHS) acute care hospitals experience lower-than-expected patient volumes in the second quarter, inducing a decline in revenues and profits.
